3rd Quarter - Termination

MEDIMMUNE, LLC. for MEDIMMUNE LLC

Firm
Client
Income
—
Expenses
$240,000
Expense method
A: Lobbying Disclosure Act definitions
Terminated
Sep 30, 2013

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to Medicaid coverage and reimbursement of respiratory syncytial virus (RSV) prophylaxis, federal quality, prevention of RSV and influenza; Medicaid coverage and reimbursement of biologics; implementation of H.R. 3590/Pub. L. No. 111-148, the Patient Protection and Affordable Care Act;

Foreign entity interest: MedImmune, LLC is a subsidiary of AstraZeneca, Inc. Please note that all future MedImmune, LLC related lobbying activities will be combined and reported through parent AstraZeneca, Inc.

LobbyistCovered position, as disclosed
ANDREA WILKINSON —

Contacted: Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS)

Bills named: H.R. 3590 (113th)

Budget/Appropriations BUD

Proposed FY2014 Budgets Congressional and White House budgets--health care related provisions. Proposed FY2014 Labor, HHS; Ag and DOD Appropriations BARDA, pandemic planning & preparedness; HR2775 FY2014 Continuing Resolution

Foreign entity interest: MedImmune, LLC is a subsidiary of AstraZeneca, Inc. Please note that all future MedImmune, LLC related lobbying activities will be combined and reported through parent AstraZeneca, Inc.

LobbyistCovered position, as disclosed
ANDREA WILKINSON —

Contacted: Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS)

Bills named: H.R. 2775 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.